| Ammar Almasalkhi, MD | |
|
4010 Dupont Cir Ste 122, Louisville, KY 40207-4842 | |
| (502) 587-9140 | |
| (502) 587-9142 |
| Full Name | Ammar Almasalkhi |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 31 Years |
| Location | 4010 Dupont Cir Ste 122, Louisville, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447230651 | NPI | - | NPPES |
| 638630 | Other | KY | WELLCARE - PULMONARY SPECIALISTS OF LOUISVILLE |
| 000000993973 | Other | KY | ANTHEM - SLEEP CARE SPECIALIST |
| 64296783 | Medicaid | KY | |
| 50101118 | Other | KY | PASSPORT - SLEEP CARE SPECIALIST |
| 200144370A | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 29678 (Kentucky) | Secondary |
| 207RS0012X | Internal Medicine - Sleep Medicine | 29678 (Kentucky) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Norton Hospitals, Inc | Louisville, KY | Hospital |
| Baptist Health Louisville | Louisville, KY | Hospital |
| Entity Name | Pulmonary Specialists Of Louisville Psc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598819724 PECOS PAC ID: 5991799801 Enrollment ID: O20040413001339 |
News Archive
An experimental drug developed by Australian scientists could offer a new cure for jet lag and be a welcome alternative to addictive sedatives such as benzodiazepines.
For the second time in a month, a federal judge has temporarily halted a law aimed at abortion clinics. U.S. District Judge J. Thomas Marten issued a preliminary injunction Monday that blocks Kansas from stripping federal family-planning funds from Planned Parenthood. He ordered the state to start distributing the money to the agency.
IRIS International, Inc., a leading manufacturer of automated in-vitro diagnostics systems and consumables for use in hospitals and commercial laboratories worldwide, today announced that, effective immediately, its Board of Directors has approved a repurchase program for up to $10 million in shares of the Company's common stock over a twelve month period.
PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat infectious diseases and acute cardiovascular disorders, has initiated a Phase 2 clinical trial, following conclusion of a review by the United States Food and Drug Administration (FDA) of a protocol submitted by PolyMedix, to assess the safety and efficacy of its heptagonist, PMX-60056, in reversing heparin in patients undergoing Percutaneous Coronary Intervention (PCI) procedures.
People with bipolar disorder or manic depression suffer from an accelerated shrinking of their brain, researchers at the University of Edinburgh have found.
› Verified 8 days ago
| Entity Name | Sleep Care Specialist Of Louisville |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841661410 PECOS PAC ID: 9931402377 Enrollment ID: O20160119002531 |
News Archive
An experimental drug developed by Australian scientists could offer a new cure for jet lag and be a welcome alternative to addictive sedatives such as benzodiazepines.
For the second time in a month, a federal judge has temporarily halted a law aimed at abortion clinics. U.S. District Judge J. Thomas Marten issued a preliminary injunction Monday that blocks Kansas from stripping federal family-planning funds from Planned Parenthood. He ordered the state to start distributing the money to the agency.
IRIS International, Inc., a leading manufacturer of automated in-vitro diagnostics systems and consumables for use in hospitals and commercial laboratories worldwide, today announced that, effective immediately, its Board of Directors has approved a repurchase program for up to $10 million in shares of the Company's common stock over a twelve month period.
PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat infectious diseases and acute cardiovascular disorders, has initiated a Phase 2 clinical trial, following conclusion of a review by the United States Food and Drug Administration (FDA) of a protocol submitted by PolyMedix, to assess the safety and efficacy of its heptagonist, PMX-60056, in reversing heparin in patients undergoing Percutaneous Coronary Intervention (PCI) procedures.
People with bipolar disorder or manic depression suffer from an accelerated shrinking of their brain, researchers at the University of Edinburgh have found.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ammar Almasalkhi, MD 3 Audubon Plaza Dr, Suite 620, Louisville, KY 40217-1300 Ph: (502) 587-9140 | Ammar Almasalkhi, MD 4010 Dupont Cir Ste 122, Louisville, KY 40207-4842 Ph: (502) 587-9140 |
News Archive
An experimental drug developed by Australian scientists could offer a new cure for jet lag and be a welcome alternative to addictive sedatives such as benzodiazepines.
For the second time in a month, a federal judge has temporarily halted a law aimed at abortion clinics. U.S. District Judge J. Thomas Marten issued a preliminary injunction Monday that blocks Kansas from stripping federal family-planning funds from Planned Parenthood. He ordered the state to start distributing the money to the agency.
IRIS International, Inc., a leading manufacturer of automated in-vitro diagnostics systems and consumables for use in hospitals and commercial laboratories worldwide, today announced that, effective immediately, its Board of Directors has approved a repurchase program for up to $10 million in shares of the Company's common stock over a twelve month period.
PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat infectious diseases and acute cardiovascular disorders, has initiated a Phase 2 clinical trial, following conclusion of a review by the United States Food and Drug Administration (FDA) of a protocol submitted by PolyMedix, to assess the safety and efficacy of its heptagonist, PMX-60056, in reversing heparin in patients undergoing Percutaneous Coronary Intervention (PCI) procedures.
People with bipolar disorder or manic depression suffer from an accelerated shrinking of their brain, researchers at the University of Edinburgh have found.
› Verified 8 days ago
Cindy J Code, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 3950 Kresge Way, Suite 303, Louisville, KY 40207 Phone: 502-896-1880 Fax: 502-896-1887 | |
Dr. Uchenna Loretta Ozor, M.D Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 200 E Chestnut St Bldg Suite303, Louisville, KY 40202 Phone: 502-629-5552 Fax: 502-629-3132 | |
Mohamed Hegazi, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 529 S Jackson St, Louisville, KY 40202 Phone: 502-562-4270 | |
Dr. Michael Patrick Krease, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1169 Eastern Pkwy Ste G58, Louisville, KY 40217 Phone: 502-452-9567 | |
Dr. Ramsey Nasri Nassar, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 6400 Dutchmans Pkwy, Ste 250, Louisville, KY 40205 Phone: 502-587-9660 Fax: 502-540-5615 | |
Jeanne M Thompson, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3 Audubon Plaza Dr, Ll2, Louisville, KY 40217 Phone: 502-636-8095 Fax: 502-636-8097 | |
Terrence P Donohue, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3101 Poplar Level Rd Ste 101, Louisville, KY 40213 Phone: 502-636-7444 Fax: 502-636-7112 |